SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids

BACKGROUND: Patients with severe viral pneumonia are likely to receive high-dose immunomodulatory drugs to prevent clinical worsening. Aspergillus species have been described as frequent secondary pneumonia agents in severely ill influenza patients receiving steroids. COVID-19 patients admitted to I...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasoni, Natalia, Rodriguez Müller, Milton, Posse, Graciela, González, Jorge, Leonardelli, Florencia, Garcia-Effron, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Española de Micología. Published by Elsevier España, S.L.U. 2021
Materias:
Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700005/
https://www.ncbi.nlm.nih.gov/pubmed/33500209
http://dx.doi.org/10.1016/j.riam.2020.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700005/
https://www.ncbi.nlm.nih.gov/pubmed/33500209
http://dx.doi.org/10.1016/j.riam.2020.11.001

Ejemplares similares